[1]Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012［J］.CA Cancer J Clin，2015,65(2):87-108.
[2]Liu WN,Qi JL,Liu JM,et al.Disease burden of lung cancer in the Chinese population,in 1990 and 2013［J］.Chin Epidemiol,2016,37(6):752-757.［刘韫宁,齐金蕾,刘江美,等.1990年与2013年中国人群肺癌疾病负担分析［J］.中华流行病学杂志,2016,37(6):752-757.］
[3]Noone AM,Cronin KA,Altekruse SF,et al.Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program,1992-2013［J］.Cancer Epidemiol Biomarkers Prev,2016,7(2):520-521.
[4]Chen W,Zheng R,Zhang S,et al.Global cancer statistics,2012［J］.Ann Transl Med,2014,2(7):61-65.
[5]Peng H,Han BH,Li XQ,et al.Analysis of clinical characteristics and prognosis in 1279 lung cancer patients［J］.China Oncol,2011,21(5):354-358.［彭红,韩宝惠,李小青,等.1279例肺癌患者临床特征及生存率分析［J］.中国癌症杂志,2011,21(5):354-358.］
[6]Yan Y,Liu XG,Cai KC,et al.Impact of surgical resection on stage Ⅱ-Ⅲa small-cell lung carcinoma patients，prognosis［J］.J Prac Med,2016,32(12):1959-1962.［闫琰,刘曦光,蔡开灿,等.手术切除对于Ⅱ-Ⅲa期小细胞肺癌患者的预后影响［J］.实用医学杂志,2016,32(12):1959-1962.］
[7]Siegel R,Naishadham D,Jemal A.Caner statistics,2013［J］.CA Cancer J Clin,2013,63(1):11-30.
[8]Qin YQ,Tao M,Chen YN,et al.Analysis of clinical characteristics and prognosis in 1288 lung cancer patients［J］.Jilin Medical J,2016,37(3):536-539.［秦艳青,陶敏,陈亚男,等.1288例原发性肺癌的临床特征及预后分析［J］.吉林医学,2016,37(3):536-539.］
[9]Radziszewska A，Karczmarek-Borowska B，Gradalska Lampart M，et al.Epidemiology，prevention and risk morbidity factors for lung cancer［J］.Pol Merkur Lekarski,2015,38（224）:113-117.
[10]Varlotto JM,Yao AN,De Camp MM,et al.Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival［J］.Int J Radiat Oncol Biol Phys,2015,91(4):765-772.
[11]Lin WY,Tang J,Zeng BH.Meta-analysis on surgery in limited-stage small cell lung cancer［J］.Sun Yat-Sen University(Medical Sciences),2015,36（6):943-948.［林文苑,唐杰,曾波航.手术治疗局限期小细胞肺癌疗效的Meta分析［J］.中山大学学报(医学科学版),2015,36（6):943-948.］
[12]Wang H,Zhang Y,Gen Y.Cox regression analysis of prognostic factors of advanced non-small cell lung cancer patients treated with chemotherapy［J］.Prac J Cancer,2014,29(2):165-167.［汪华,张云,耿熠.晚期非小细胞肺癌化疗预后因素的Cox回归分析［J］.实用癌症杂志,2014,29(2):165-167.］
[13]Sun SL,Liu TQ,Wang QW,et al.Surgical treatment for 310 elderly patients with non-small cell lung cancer［J］.China Oncol,2015,25(5):382-386.［孙少林,刘铁钦,王启文,等.310例65岁以上老年人非小细胞肺癌的手术治疗［J］.中国癌症杂志,2015,25(5):382-386.］
[14]Zhang RF,Zhang Y,Wen FB,et al.Analysis of pathological types and clinical epidemiology of 6058 patients with lung cancer［J］.Chin J Lung Cancer,2016,19(3):129-135.［张仁锋,张岩,温丰标,等.6058例肺癌患者病理类型和临床流行病学特征的分析［J］.中国肺癌杂志,2016,19(3):129-135.］
[15]Chen KN.Do multidisciplinary team meetings make a difference in the management of lung cancer［J］.J Clin Surg,2016,24(7):482-486.［陈克能.如何保持外科医师在胸部肿瘤多学科中的积极作用［J］.临床外科杂志,2016,24(7):482-486.］